In Bernard‑Soulier disease, the giant platelets that fail to aggregate with ristocetin are deficient in which of the following: glycoprotein Ib (GPIb) platelet receptor, dense granules, glycoprotein IIb/IIIa receptor, or alpha granules?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bernard-Soulier Disease: Glycoprotein Ib Deficiency

The answer is A: Glycoprotein Ib platelet receptor. Bernard-Soulier syndrome is definitively characterized by deficiency or dysfunction of the GPIb-V-IX complex, which causes the characteristic failure of platelet aggregation with ristocetin and the presence of giant platelets 1.

Diagnostic Hallmarks

The pathognomonic laboratory findings in Bernard-Soulier syndrome are:

  • Defective expression of GPIb/IX on flow cytometry - This is the definitive diagnostic test showing absent or markedly reduced GPIb (CD42b) and GPIb/IX (CD42a) expression 1
  • Absent ristocetin-induced platelet aggregation - Platelets fail to aggregate with ristocetin because GPIb is the receptor that binds von Willebrand factor in the presence of ristocetin 1
  • Giant platelets (macrothrombocytopenia) - Characteristically large platelets with thrombocytopenia 2, 3, 4, 5
  • Normal aggregation to other agonists - Aggregation to ADP, collagen, and arachidonic acid remains normal, distinguishing it from Glanzmann thrombasthenia 6

Molecular Basis

The GPIb-V-IX complex is a multisubunit receptor composed of GPIbα (disulfide-linked to GPIbβ) and noncovalently associated with GPIX and GPV 5. Mutations have been identified in the genes encoding GPIbα (GP1BA on chromosome 17p12), GPIbβ (GP1BB on chromosome 22q11.2), and GPIX (GP9 on chromosome 3q21), but not in GPV 2, 4. These mutations either prevent surface expression of the complex or alter its functional conformation 7, 4.

Why Not the Other Options

Dense granules (Option B) and alpha granules (Option D) are NOT deficient in Bernard-Soulier syndrome:

  • Dense granule deficiency characterizes δ-storage pool disease (δ-SPD), Hermansky-Pudlak syndrome, and Chediak-Higashi syndrome 1
  • Alpha granule deficiency characterizes Grey Platelet Syndrome (GPS) 1
  • Bernard-Soulier syndrome shows normal granule content and release 2, 3

Glycoprotein IIb/IIIa receptor (Option C) is NOT deficient in Bernard-Soulier syndrome:

  • GPIIb/IIIa deficiency is the hallmark of Glanzmann thrombasthenia, not Bernard-Soulier syndrome 1, 6
  • In Glanzmann thrombasthenia, platelets fail to aggregate with ALL agonists except ristocetin (the opposite pattern from Bernard-Soulier syndrome) 6
  • Bernard-Soulier platelets have normal GPIIb/IIIa expression 3, 5

Clinical Pitfall

Do not confuse the ristocetin aggregation patterns:

  • Bernard-Soulier syndrome: Absent ristocetin aggregation, normal aggregation to other agonists 1
  • Glanzmann thrombasthenia: Normal ristocetin aggregation, absent aggregation to other agonists 6
  • Platelet-type von Willebrand disease: Enhanced ristocetin aggregation at low concentrations 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Bernard-Soulier syndrome (hemorrhagiparous thrombocytic dystrophy).

Orphanet journal of rare diseases, 2006

Research

Bernard-Soulier syndrome.

Bailliere's clinical haematology, 1989

Research

Genetic abnormalities of Bernard-Soulier syndrome.

International journal of hematology, 2002

Research

Bernard-Soulier syndrome: an update.

Seminars in thrombosis and hemostasis, 2013

Guideline

Treatment of Qualitative Platelet Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.